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The equine herpesvirus 1 (EHV-1) homolog of the herpes simplex virus type 1 (HSV-1) tegument phosphoprotein, aTIF
(Vmw65; VP16), was identified previously as the product of open reading frame 12 (ORF12), was shown to trans-activate
immediate-early (IE) gene promoters, and was described as a 60-kDa virion component designated ETIF. However, the ETIF
promoter region and transcription initiation site were not identified. The poly(A) signal of the gene 11 (UL49 homolog) lies just
upstream of the first ETIF translation initiation codon, indicating that the first ATG may not be used for initiating ETIF
translation. Another in-frame translation initiation codon (ATG2) is located 88 bp downstream of the first ETIF initiation codon
(ATG1). Western blot analysis showed that the expressed ETIF protein migrated in SDS–PAGE with an apparent molecular
mass of approximately 56 kDa, the same molecular weight identified in SDS–PAGE analysis of the KyD EHV-1 virion
preparations. The ETIF expression vector pCETIF, which contains ATG2, trans-activated the IE promoter more efficiently than
the pC12 containing both ATG1 and ATG2. S1 nuclease analyses mapped the 59 initiation site of the 1.4-kb transcript
approximately 17 to 21 nt downstream of the ATG1. The nucleotide sequence upstream of the ATG1 did not have any
promoter activity, while the nucleotide sequence upstream of the ATG2 had promoter activity. In transient transfection
assays, the pETIFM2 vector, which was mutated in the ATG2, did not trans-activate the IE promoter; however, the pETIFM1
vector, which was mutated in the ATG1, trans-activated the IE promoter. These results demonstrated that the ATG2 of the
ETIF ORF is the ETIF translation initiation codon. ETIF trans-activated only the IE promoter, not early (EICP0, EICP22,
EICP27, and thymidine kinase) or late (IR5) promoters, confirming that EICP0, EICP22, and EICP27 are early genes. © 2001
Academic Press
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The 77 genes of EHV-1 are transcribed in an ordered
and temporally controlled cascade termed immediate-
early (IE), early (E), and late (L) (Caughman et al., 1985;
Gray et al., 1987; O’Callaghan and Osterrieder, 1999). The
IE gene of EHV-1 is essential for replication (Garko-
Buczynski et al., 1998), lies within each of the two in-
erted repeats, and encodes a 1487-amino-acid (aa)
olypeptide (IE) (Grundy et al., 1989). The IE protein
rans-activates EHV-1 and heterologous viral promoters,
rans-represses its own expression, and acts synergisti-
ally with the EICP22 and EICP27 proteins to trans-
ctivate the E and L promoters (Holden et al., 1995;
atsumura et al., 1993; Smith et al., 1992; Zhao et al.,
1995). Residues 422 to 597 of the IE protein are sufficient
for its sequence-specific DNA binding to nucleotides that
overlap the transcription initiation site of the IE gene and
to sequences in the E and L promoters that contain a
degenerate version of the consensus binding sequence
1 To whom correspondence and reprint requests should be ad-
ressed at Department of Microbiology and Immunology, Louisiana
tate University Health Sciences Center, 1501 Kings Highway, P.O. Box
3932, Shreveport, LA 71130-3932. Fax: (318) 675-5764. E-mail:
OCALL@LSUHSC.EDU.
23759-ATCGT-39 (Kim et al., 1995). The EICP22 protein phys-
ically interacts with the IE protein (Derbigny et al., 2000)
and increases its in vitro DNA binding activity for se-
quences in the IE, E, and L promoters (Kim et al., 1997).
potent transcriptional activation domain lies within the
irst 89 aa residues of the IE protein (Buczynski et al.,
999; Smith et al., 1994), and aa 963 to 970 are necessary
or nuclear localization of the truncated IE polypeptides
Smith et al., 1995). The IE protein binds to the transcrip-
ion initiation site of the gK promoter sequences, thereby
epressing transcription of this true late gene (Kim et al.,
999). The EICP0 protein can independently activate ex-
ression of all classes of EHV-1 promoters and is the
nly EHV-1 regulatory protein capable of independently
ctivating a g2 late promoter (Bowles et al., 1997). The
EHV-1 IE and EICP0 proteins are potent trans-activators
of EHV-1 promoters, but they do not function synergisti-
cally, but exhibit an antagonistic relationship (Kim et al.,
1999; Bowles et al., 2000).
Previous studies showed that EHV-1 particles trans-
activate expression of the IE gene (Purewal et al., 1992).
This virion-associated activity was ascribed to the prod-
uct of EHV-1 open reading frame 12 (ORF 12; Lewis et al.,
1993; Purewal et al., 1994), which exhibits significant
sequence homology with the herpes simplex virus type 1
(HSV-1) a-transinducing factor (aTIF) gene, UL48, and
0042-6822/01 $35.00
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238 KIM AND O’CALLAGHANvaricella zoster virus (VZV) ORF10 (Campbell et al., 1984;
Gerster and Roeder, 1988; Kristie et al., 1989; McGeoch
et al., 1988; Telford et al., 1992). Homologs of aTIF have
een characterized for several other alphaherpesvi-
uses, including HSV-1 (Pellett et al., 1985), HSV-2
Greaves and O’Hare, 1991), VZV (Moriuchi et al., 1993),
nd bovine herpesvirus (BHV; Misra et al., 1994), EHV-1
(Lewis et al., 1997). The VZV, HSV-1, and EHV-1 aTIFs
referred to as VTIF, VP16, and ETIF, respectively) were
dentified as structural components of the tegument
Campbell et al., 1984; Heine et al., 1974; Lewis et al.,
1997). However, mutational analysis revealed that VP16
is essential for HSV-1 capsid maturation and virion as-
sembly (Weinheimer et al., 1992; Ace et al., 1989),
hereas VTIF is dispensable (Cohen and Seidel, 1994).
hese observations suggest that the role of VTIF as a
irion component differs significantly from that of its HSV
ounterpart. These aTIF proteins also differ in their pri-
ary structures and trans-activation domains. VP16 re-
uires an acidic C-terminus, which was identified as its
rans- activation domain, whereas functional VTIF lacks
he corresponding final 80 acidic aa (Moriuchi et al.,
993; Misra et al., 1994; Ace et al., 1988; Triezenberg et
al., 1988a). Sequence analysis of the EHV-1 ORF12 gene
indicated that, like VZV, the ETIF protein lacks the acidic
C-terminal trans-activation domain (Telford et al., 1992).
Furthermore, mutational analysis of ETIF indicated that
the C-terminal 7 aa residues appear to be necessary, but
are not sufficient, for ETIF trans-activation function (Eliott,
1994). In addition, fusion proteins containing the VP16
protein binding domain and ETIF C-terminal region did
not exhibit trans-inducing activity, suggesting that se-
quences from other regions of ETIF are required (Elliott,
1994). The ETIF gene is a member of the late (g2) class of
HV-1 genes as its synthesis is almost dependent upon
NA replication (Lewis et al., 1997; Bowles et al., 1997).
In an HSV-1 infection, IE gene trans-activation is me-
iated by a multiprotein complex that includes the virion
tructural protein VP16, the ubiquitous cellular transcrip-
ion factor Oct-1 (Preston et al., 1988; O’Hare and Goding,
988; O’Hare et al., 1988), and another cellular compo-
ent designated HCF (Gerster and Roeder, 1988; Kristie
t al., 1989; Xiao and Capone, 1990). VP16 does not bind
irectly to DNA but rather interacts with the OCT-1 pro-
ein bound directly to the consensus TAATGARAT (R 5
urine) motif, a conserved sequence present in all five
SV-1 IE promoters (Mackem and Roizman, 1982; Kristie
nd Roizman, 1984) as well as in the promoter of the
ingle EHV-1 IE gene (Purewal et al., 1992). While VP16/
TAATGARAT complexes were demonstrated in DNA
band shift studies (Greaves and O’Hare, 1989), similar
complexes were not identified with ETIF. Elliott and
O’Hare (1995) found that other octamer elements in the
EHV-1 IE promoter are targets for ETIF/Oct-1 complex
formation and may play a role in ETIF mediated trans-
ctivation.The EHV-1 tegument phosphoprotein, ETIF, was
shown to trans-activate IE gene promoters (Lewis et al.,
1993) and was identified as a 60-kDa virion component
(Lewis et al., 1997). However, the ETIF promoter region
and transcription initiation site were not identified. We
report here that the in-frame ATG2 located 88 bp down-
stream of the first ETIF initiation codon is the ETIF trans-
lation initiation site. The ETIF protein trans-activated only
the IE promoter, not the E and L promoters, confirming
that EICP0, EICP22, and EICP27 are early genes.
RESULTS
The EHV-1 ETIF does not use the ATG1 codon for
translation initiation
In a previous study, EHV-1 ETIF was identified as a
60-kDa virion component (Lewis et al., 1997), but the ETIF
promoter region and transcription initiation site were not
identified. The poly(A) signal of gene 11 (UL49 homolog)
lies just upstream of the first ETIF translation initiation
codon, indicating that the first ATG may not be used for
the ETIF translation initiation. Another possible in-frame
translation initiation codon (ATG2) is located 88 bp down-
stream of the first ETIF initiation codon (ATG1) (Figs. 1A
and 5). To investigate which ATG is employed for initiat-
ing ETIF translation, two ETIF expression vectors were
constructed and examined in Western blot analyses and
CAT assays. The plasmid pC12 vector expresses ETIF
under the control of the CMV promoter and contains both
ATG1 and ATG2; the pCETIF vector contains only ATG2.
The two plasmids were transfected into mouse fibroblast
L-M cells, and the ETIF protein was detected by Western
blot analysis (Fig. 1B). Interestingly, both the pC12 and
pCETIF vectors expressed only one species of the ETIF
protein, which migrated in SDS–PAGE with an apparent
molecular mass of 56 kDa (Fig. 1B, lanes 3 and 4,
respectively). EHV-1 strain KyD virions were used to
provide an ETIF marker (Fig. 1B, lane 5). The expressed
ETIF protein migrated in SDS–PAGE with an apparent
molecular mass of 56 kDa, as did the ETIF present in KyD
EHV-1 purified virions.
To investigate whether the expressed ETIF is able to
trans-activate the IE promoter, transient transfection as-
says were performed with the ETIF expression vectors
and EHV-1 promoter reporter plasmids. The ETIF expres-
sion vector pCETIF trans-activated the IE promoter more
efficiently than did pC12 that contains both ATG1 and
ATG2 (Fig. 1C, bars 2 and 3, respectively). These results
indicated that the ATG2 might be used for the translation
initiation site of the ETIF ORF.
S1 nuclease analysis of the 59 end of the ETIF
transcriptS1 nuclease analysis was performed to identify the
transcriptional initiation site of the ETIF mRNA. It was
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239THE EHV-1 ETIFshown previously that a 1.4-kb ETIF mRNA was detected
in abundance in infected cell cultures (Lewis et al., 1997).
o map the 59 terminus of the 1.4-kb transcript, we la-
eled clone PE at its 59 end with [g-32p]ATP and T4
polynucleotide kinase. This 59-end-labeled probe was
allowed to hybridized to poly(A)1 RNAs isolated from
mock-infected cells (Fig. 2, lane 5) and EHV-1-infected
cells were collected at late times of infection (Fig. 2, lane
6). After digestion with S1 nuclease, the protected frag-
ments were fractionated on a 6% polyacrylamide–urea
gel. The DNA sequence of pUC19 served as molecular
weight markers (Fig. 2, lanes 1 to 4). Two major frag-
ments of 213 and 217 nucleotides were detected in the
mRNA isolated from infected cells (Fig. 2, lane 6). As
expected, probe PE failed to hybridize to mRNA from
mock-infected cells (Fig. 2, lane 5). These results
mapped the 59 initiation site of the 1.4-kb transcript to lie
approximately 17 to 21 nucleotides downstream of the
ETIF ATG1 (Fig. 5), indicating that the first ETIF ATG
codon (ATG1) may not be used for ETIF translation initi-
FIG. 1. The EHV-1 ETIF does not use ATG1 for translation initiation
gene. Poly(A)1, polyadenylation signal; ATG1, TL
i #1 (see Fig. 5); AT
ovirus IE gene promoter. (B) Western blot analysis of the ETIF prote
ere purified from infectious supernatant as previously described (P
ndicated in kilodaltons. (C) Transient transfection assays with ETIF
lasmid pIE-CAT and 0.3 pmol of effector plasmids (pC12 and pCETI
ars show standard deviations.ation. These two protected fragments may represent two
different transcription initiation sites.
C
CThe nucleotide sequence upstream of ATG1 does not
have promoter activity
To identify the ETIF promoter region, three possible
ETIF promoter–CAT chimeric plasmids were constructed
(Fig. 3A), and their promoter activities were tested (Fig.
3B). pETIF1-CAT contains the sequences (2378 to 291;
see top diagram of Fig. 3A) upstream of the ATG1 of the
ETIF gene. pETIF2-CAT and pETIF3-CAT contain the se-
quences (2378 to 28) and (2198 to 28) upstream of the
ATG2, respectively. Transient transfection assays were
performed with the pETIF-CAT chimeric plasmids. The
reporters pETIF2-CAT and pETIF3-CAT showed relatively
high CAT activity compared to that of pETIF1-CAT (less
than 2%). The IE protein by itself trans-activated pETIF2-
CAT and pETIF3-CAT by two- to threefold (Fig. 3B, bars 6
and 10, respectively), but not pETIF1-CAT (less than two-
fold) (Fig. 3B, bar 2). The EICP0 protein is the only EHV-1
regulatory protein capable of independently activating a
g2 late promoter (Bowles et al., 1997). The EICP0 protein
y itself strongly trans-activated pETIF2-CAT and pETIF3-
IF expression vectors. The top diagram represents the EHV-1 ETIF
#2 (see Fig. 5); TGA, termination codon; CMV-P, human cytomega-
an ETIF-specific mAb (Lewis et al., 1997). The KyD virions of EHV-1
et al., 1974). The position of ETIF is indicated by an arrow. Sizes are
ssion vectors. L-M cells were transfected with 0.5 pmol of reporter
h transfection was performed in triplicate. Data are averages; error. (A) ET
G2, TL
i
in with
erdue
expre
F). EacAT (Fig. 3B, bars 7 and 11, respectively), but not pETIF1-
AT (Fig. 3B, bar 3), indicating that the two reporter
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240 KIM AND O’CALLAGHANplasmids pETIF2-CAT and pETIF3-CAT posses promoter
activity and that the nucleotide sequence downstream of
the ATG1 codon is important for ETIF promoter activity.
The EICP0 and IE proteins have an antagonistic rela-
tionship (Bowles et al., 2000), and this was also observed
in the case of the ETIF promoter. As mentioned before,
both the IE and EICP0 proteins independently trans-
activated the ETIF promoter (Fig. 3B, bars 6 and 10 and
bars 7 and 11, respectively). However, the EICP0 and IE
proteins did not function synergistically to trans-activate
the ETIF promoter (Fig. 3B, bars 8 and 12), indicating that
the IE protein inhibited the ability of the EICP0 protein to
activate expression of the ETIF promoter. Our unpub-
lished data showed that the IE and EICP0 proteins an-
tagonizes by competing for cellular transcription factor
TFIIB to trans-activate EHV-1 genes.
he pETIFM2 vector that harbors a mutated ATG2 of
he ETIF gene does not trans-activate the IE promoter
To confirm that ATG2 is used for ETIF translation ini-
tiation, constructs harboring mutations in the ETIF initi-
FIG. 2. S1 nuclease analysis of the 59 end of the ETIF transcript. The
radiolabeled probe PE (see Materials and Methods) was hybridized to
poly(A)1 RNAs from mock-infected (lane 5) and EHV-1-infected cells
lane 6) and digested with S1 nuclease. The S1-resistant fragments
ere fractionated on a 6% polyacrylamide–urea gel. The DNA se-
uence of pUC19 served as molecular weight marker (lanes 1 to 4).
sterisk indicates 32P-labeled site. DNA sequencing was performed
ith the fmol Sequencing System (Promega, Madison, WI).ation codons were generated and used in CAT assays
(Fig. 4A). pETIFM1 was mutated in the first ATG codon
f
d(ATG 3 ATT), whereas pUETIFM2 was mutated in the
second ATG codon (ATG3 CTG) of the ETIF ORF. In the
ase of the expression vectors pUETIF, pUETIFM2, and
UETIFM2, each uses its own promoter to express ETIF.
n transient transfection assays performed with the mu-
ant ETIF expression vectors, pETIF and pETIFM1
trongly trans-activated the pIE-CAT reporter (Fig. 4). As
xpected, the pETIFM2 vector failed to trans-activate the
IE-CAT reporter plasmid, indicating that the second ATG
odon (ATG2) is the ETIF translation initiation codon
Fig. 4).
The ETIF open reading frame (ORF) and several po-
ential cis-acting regulatory elements are illustrated in
ig. 5. The two ATG codons, located at nt 265 to 267 and
55 to 357, respectively, are present at the N-terminus of
he ETIF ORF. Our data indicated that the second in-
rame ATG codon is the ETIF translation initiation site.
he sequences upstream and downstream of the ETIF
RF contain several potential cis-acting elements (Fig.
). These include three possible TATA boxes located at nt
34 to 239, 259 to 264, 275 to 280 and a polyadenylation
onsensus signal (AATAAA) at nt 1708 to 1713, which is
ownstream of the TAA stop codon at nt 1701 to 1703. As
entioned before, the poly(A) signal of the gene 11 (UL49
omolog) is just upstream (nt 259 to 264) of the first ETIF
TG codon, indicating that this codon may not be used
FIG. 3. Identification of the ETIF promoter region. (A) Schematic
diagram of the ETIF promoter–CAT chimeric plasmids. Three possible
ETIF promoter region–CAT chimeric plasmids were constructed. The
top diagram represents the ETIF promoter. Poly(A)1, polyadenylation
signal; ATG1, TL
i #1 (see Fig. 5); ATG2, TL
i #2 (see Fig. 5); IEBS, the EHV-1
E protein binding site. The numbers refer to the number of nucleotides
rom the ATG2. (B) Transient transfection assays with the ETIF-CAT
himeric plasmids. L-M cells were transfected with 1.4 pmol of reporter
lasmids (pETIF1-CAT, pETIF2-CAT, and pETIF3-CAT) and 0.3 pmol of
ffector plasmids (pSVIE and pSVEICPOK). Each transfection was per-ormed in triplicate. Data are averages; error bars show standard
eviations.
(
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241THE EHV-1 ETIFfor the ETIF translation initiation. The ETIF ORF begins at
nt 355 and ends at nt 1703, and thus the predicted ETIF
protein is composed of 449 amino acids and has a
predicted molecular mass of 49.4 kDa.
The ETIF protein trans-activates only the IE promoter
To investigate whether the ETIF protein can trans-
activate the IE, E, and L promoters, transient transfection
assays were performed with the various EHV-1 promot-
er–CAT constructs. The ETIF protein was able to inde-
pendently trans-activate expression of the IE promoter
(Fig. 6A, bar 3). However, the ETIF protein was not able
to trans-activate expression of the early EICP0, EICP22,
EICP27, and thymidine kinase (TK) promoters or the late
IR5 promoter (Fig. 6B bar 3, 6C bar 3, 6D bar 3, 6E bar 3,
6F bar 3, respectively). The IE protein or the EICP0
protein as a positive control trans-activated the IE (Fig.
6A bar 2), EICPO (Fig. 6B bar 2), EICP22 (Fig. 6C bar 2),
EICP27 (Fig. 6D bar 2), TK (Fig. 6E bar 2), and IR5 (Fig. 6F
bar 2) promoters. These results confirmed that regulatory
genes EICP0, EICP22, and EICP27 are early genes. As
mentioned before, EHV-1 EICP22 (Holden et al., 1992),
EICP27 (Zhao et al., 1992), and EICP0 (Bowles et al.,
1997) are regulated as E genes, in contrast to the case
FIG. 4. Mutational analysis of the ETIF ORF. (A) Schematic diagram
of the mutated ETIF expression vectors. Two constructs containing
individual mutations in the ETIF initiation codons were generated and
used for CAT assays. pETIF contains a 1615-bp XbaI–SphI fragment of
the EHV-1 ETIF gene cloned into the pUC19 vector. pETIFM1 was
mutated in the first ATG codon of the ETIF ORF. pETIFM2 was mutated
in the second ATG codon of the ETIF ORF. The top diagram represents
the EHV-1 ETIF gene. Poly(A)1, polyadenylation signal; ATG1, TL
i #1 (see
Fig. 5); ATG2, TL
i #2 (see Fig. 5). (B) Transient transfection assays with
the mutant ETIF expression vectors. L-M cells were transfected with 1.4
pmol of reporter plasmid pIE-CAT and 0.3 pmol of effector plasmids
(pETIF, pETIFM1, and pETIFM2). Each transfection was performed in
triplicate. Data are averages; error bars show standard deviations.for HSV-1, in which they are members of the IE gene
family (Anderson et al., 1980; Honess and Roizman, 1974; pJones et al., 1977; Mackem and Roizman, 1981; Preston
et al., 1978; Watson et al., 1979).
DISCUSSION
In this paper, we present evidence that the EHV-1 ETIF
uses an in-frame translation initiation codon (ATG2) lo-
cated 88 bp downstream of ATG1. Also we characterized
the ETIF promoter region and transcription initiation site.
Figure 7 presents a comparison of the sequence of the
N-terminus of the EHV-1 ETIF protein and its homologs in
EHV-4, HSV-1, and VZV. These alphaherpesviral proteins
do not show a significant degree of homology at the
N-terminus (aa 1 to 48); however, their translation start
sites are quite similar. VP16 consists of an N-terminal
domain (aa 49 to 390) involved in recruiting VP16 to a
multicomponent DNA binding complex with two host
proteins, Oct-1 and host cell factor (HCF), and an acidic
C-terminal domain exclusively involved in trans-activation
(Dalrymple et al., 1985; Pellett et al., 1985; Ace et al., 1988;
Triezenberg et al., 1988b; Greaves and O’Hare, 1990;
Grapes and O’Hare, 2000). The ETIF protein exhibits strong
conservation with the N-terminal domain (aa 49 to 390) of
VP16 but, with the exception of a short segment at the
extreme C-terminus, lacks almost the entire acidic C-termi-
nal domain (Grapes and O’Hare, 2000). These results sug-
gested that the N-terminal domain (aa 1 to 48) of the VP16
homologs are not important for trans-activation function.
ETIF is able to trans-activate the IE promoter (Lewis et
al., 1993; Holden et al., 1995). We showed that the 449-aa
ETIF protein produced by pCETIF that lacks ATG1 was
able to independently trans-activate the IE promoter,
supporting the conclusion that this is the functional form
of ETIF. The finding that the ETIF protein was not able to
activate expression of the EICP0, EICP22, and EICP27
confirmed our assignment of these EHV-1 genes as early
genes, in contrast to the situation in HSV-1, in which their
homologs are immediate-early genes.
Expression of EHV-1 genes is coordinately expressed
and temporally regulated in IE, E, and L fashions (Caugh-
man et al., 1985; Gray et al., 1987)). In the immediate-
early stage of infection, the ETIF protein enhances the
expression of the IE gene (Lewis et al., 1993; Holden et
al., 1995). At early times, the IE protein activates the
expression of the early genes, including EICP22 and
EICP27, which act in concert with the IE protein to en-
hance early gene expression (Holden et al., 1995; Smith
et al., 1992; Zhao et al., 1995; Matsumura et al., 1993).
However, the IE protein independently is not able to
trans-activate the g1 (IR5; gD) or g2 late (gK) genes
Holden et al., 1995; Kim et al., 1999). The finding in this
eport that the IE protein also fails to activate expression
f the ETIF gene, another g2 late gene, supports our
hypothesis that the IE protein by itself is not able to turn
on the expression of the g1 and g2 L genes. The EICP0
rotein by itself strongly trans-activates the ETIF pro-
242 KIM AND O’CALLAGHANFIG. 5. DNA sequence and predicted aa sequence of the EHV-1 ETIF. The ETIF ORF maps between nt 355 and 1700. The amino acid sequence
of ETIF is shown by the single letter code beneath the DNA sequence. The numbering of the aa begins with the first methionine. Potential cis-acting
i 1 ielements are shown by the following symbols: Tc, transcription initiation site (cap site); poly(A) , polyadenylation signal; TL #1, first ETIF ATG codon
(previous translation initiation site); TL
i #2, second ETIF ATG codon.
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243THE EHV-1 ETIFmoter, consistent with our previous results that the
EICP0 protein is the only regulatory protein capable of
independently activating g2 late gene expression
Bowles et al., 1997). The EICP0 and EICP22 proteins
function synergistically to trans-activate the g2 L pro-
oter (Bowles et al., 2000). Taken together, these obser-
ations suggest that the EICP0 protein is a regulatory
actor that contributes to the switch from early to g1 and
g2 late gene expression and is responsible for the ex-
pression of the g2 late ETIF protein.
FIG. 6. The ETIF trans-activates the IE promoter. Transient transfect
ransfected with 1.4 pmol of reporter plasmids [pIE-CAT (A), pEICP0-C
IR5-CAT (F)], 0.01 pmol of effector plasmid pETIF, and 0.3 pmol of eff
riplicate. Data are averages; error bars show standard deviations.
FIG. 7. Comparison of the amino acid sequences of the N-terminus o
et al., 1985), and VZV gene 10 (Davison and Scott, 1986) proteins. Gaps have b
Completely conserved residues are shown in the consensus line.Last, our preliminary findings on the role of ETIF in
nitiating EHV-1 gene expression have revealed that the
TIF protein interacts with the general transcription fac-
ors human TFIIB and dTAFll40 (human TAFll32 homolog).
These interactions are likely important in the generation
of a preinitiation complex to allow transcription of the
immediate-early gene. Future work will address the na-
ture of these protein–protein interactions, which may be
essential for EHV-1 gene expression, and the role that
the ETIF protein plays in this process.
ays with the various EHV-1 promoter–CAT constructs. L-M cells were
pEICP22(E)-CAT (C), pUL3-CAT (pEICP27-CAT) (D), pTK-CAT (E), and
lasmids (pSVIE and pSVEICP0K). Each transfection was performed in
V-1 ETIF, EHV-4 ORF B5 (Purewal et al., 1994), HSV-1 VP16 (Dalrympleion ass
AT (B),
ector pf the EH
een introduced into the sequence (hyphen) to optimize the alignment.
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244 KIM AND O’CALLAGHANMATERIALS AND METHODS
Virus and cell culture
The KyD strain of EHV-1 was propagated in suspen-
sion cultures of mouse fibroblast L-M cells as previously
described (O’Callaghan et al., 1968; Perdue et al., 1974).
The KyD virions of EHV-1 were purified from infectious
supernatant as previously described (Perdue et al., 1974).
L-M cells were propagated in suspension culture with
YELP medium (Eagle’s minimum essential medium
(EMEM) supplemented with yeast extract, lactalbumin
hydrolysate, peptone) containing 0.12% methyl cellulose,
100 U of penicillin/ml, 100 mg of streptomycin/ml, and 5%
fetal bovine serum (FBS).
Plasmids
Plasmids were constructed and maintained in Esche-
richia coli HB101 by standard methods (Sambrook et al.,
989). To construct the pCETIF vector, which contained a
eletion of the ATG1 codon of the ETIF gene, the HindIII–
alI fragment of the PCR fragment amplified with primers
X-4 (59-GGGAAGCTTGACGCGCGCCCGGC-39) and
X-5 (59-GAGGTCGACAGCAGGGC-39) was cloned into
indIII–SalI-digested pC12 (a generous gift from Dr.
retchen B. Caughman, Medical College of Georgia). To
onstruct the pETIF1-CAT plasmid, the HindIII–XbaI frag-
ent of the PCR fragment amplified with primers TX-1
59-GGGAAGCTTGAACCCGCCAAAG-39) and TX-2 (59-
CTCTAGATTTTATTGAGGGCAC-39) was cloned into
indIII–XbaI-digested pCAT-basic (Promega, Madison,
isconsin). To construct the pETIF2-CAT plasmid, the
indIII–XbaI fragment of the PCR fragment amplified with
rimers TX-1 (59-GGGAAGCTTGAACCCGCCAAAG-39)
nd TX-3 (59-CCTCTAGAAGCTGCCGGGCG-39) was
loned into HindIII–XbaI-digested pCAT-basic (Promega,
adison, Wisconsin). To construct the pETIF2-CAT plas-
id, the XbaI fragment of the PCR fragment amplified
ith primers TX-1 (59-GGGAAGCTTGAACCCGCCAAAG-
9) and TX-2 (59-CCTCTAGATTTTATTGAGGGCAC-39) was
loned into XbaI-digested pCAT-basic (Promega, Madi-
on, Wisconsin). To construct the pETIF vector, the
indIII–XbaI fragment of pHIH pC12 (Lewis et al., 1993)
as cloned into HindIII–XbaI-digested pUC19. To con-
truct the pETIFM1 vector, which contained a deletion of
he ATG1 codon of the ETIF gene, the EcoRI–SalI frag-
ent of the second PCR fragment (see below) was
loned into EcoRI–SalI-digested pETIF. To construct the
ETIFM2 vector, in which the ATG2 codon of the ETIF
ene was deleted, the EcoRI–SalI fragment of the sec-
nd PCR fragment was cloned into EcoRI–SalI-digested
ETIF. To construct the pEICP0-CAT plasmid, the SpeI–
mnI fragment of the EHV-1 KyA strain subclone Sal2
Baumann et al., 1987) was cloned into SpeI–SmaI-di-
gested pSVSPORT1 vector (Life Technologies, Gaithers-
burg, MD). pIE-CAT, pSVIE, pTK-CAT, and pIR5-CAT have
p
pbeen described previously (Smith et al., 1992). pSVICP0K
(Bowles et al., 1997), pEICP22(E)-CAT (Holden et al.,
1995), and pUL3-CAT (pEICP27-CAT) (Zhao et al., 1995)
have been described previously.
Western blot analyses
Samples were boiled in 23 Laemmli sample buffer
and separated by sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS–PAGE). Separated proteins
were transferred to nitrocellulose filters (Schleicher &
Schuell, Inc., Keene, NH) at 100 V for 1 h. Blots were
blocked for 30 min in TBST [10 mM Tris–HCl (pH 8.0), 150
mM NaCl, 0.5% Tween 20] containing 10% nonfat pow-
dered milk and then incubated with a monoclonal anti-
body to ETIF (Lewis et al., 1997) (1:2000 dilution) in TBST
for 30 min. The blots were washed three times for 10 min
each in TBST and incubated with secondary antibody
[anti-mouse IgG(Fc)-alkaline phosphatase conjugate
(Promega, Madison, Wisconsin)] at a dilution of 1:4000
for an additional 30 min. The membranes were washed
in TBST for three 10-min washes, and the proteins were
visualized by incubating the membranes in AP buffer [0.1
M Tris–HCl (pH 9.5), 0.1 M NaCl, 5.0 mM MgCl2] contain-
ing nitroblue tetrazolium (0.33 mg/ml; Life Technologies)
and 5-bromo-4-chloro-3-indolyphosphate (0.165 mg/ml;
Life Technologies).
Isolation of poly(A)1 RNA
To isolate late mRNA, 1 3 108 L-M cells were infected
with EHV-1 KyA at a multiplicity of infection of 10 PFU per
cell, and the cells were harvested at 8 h postinfection.
Poly(A)1 RNA was isolated by using the Fast Track 2.0
RNA isolation kit (Invitrogen Corp., San Diego, CA) as
escribed previously (Harty and O’Callaghan, 1991).
1 nuclease analysis
S1 nuclease analysis was performed as described
lsewhere (Berk and Sharp, 1977; Harty et al., 1989;
eaver and Weissman, 1979). To prepare probe PE,
olymerase chain reaction (PCR) was performed with
rimers TX-6 (59-TTTTTCGACGACACGAAT-39) and TX-7
59-GAATGGAATAAACGGACT-39) and resulted in a
03-bp DNA fragment PE-1 (268 to 1235 relative to the
irst ATG codon of the ETIF gene). PCR amplification
onditions consisted of an initial denaturation of 5 min at
5°C followed by 40 thermal cycles of 95°C for 1 min,
0°C for 0.5 min, and 75°C for 0.5 min. The PCR fragment
E-1 (303 bp) was 59-end-labeled with [g-32p]ATP and T4
polynucleotide kinase. A 17-bp upstream DNA fragment
of radiolabeled PE-1 was deleted by digestion with the
restriction enzyme EcoRI. The resulting 286-bp probe,
PE, contains only one labeled site downstream of the
EcoRI site. The probe PE was hybridized to 3.0 mg of
1oly(A) RNA in 25 ml of S1 hybridization buffer [40 mM
iperazine-N,N9-bis(2-ethanesulfonic acid) (PIPES; pH
s
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245THE EHV-1 ETIF6.4), 400 mM NaCl, 1.0 mM EDTA, 80% formamide] at
65°C for 14 to 16 h. The DNA–RNA hybrids were digested
in 300 ml of S1 digestion buffer [250 mM NaCl, 30 mM
odium acetate (pH 4.6), 1.0 mM ZnCl2, 60 U of S1
uclease (Bethesda Research Laboratories, Inc.)] at
7°C for 30 min. The protected fragments were analyzed
n a 6% polyacrylamide–urea sequencing gel.
ite-directed mutagenesis by polymerase chain
eaction
The site-directed mutagenesis was performed by PCR
ith oligonucleotides containing point mutations (Kim et
l., 1992). Two subsequent PCR steps were required. In
he first step, the PCR was performed with a mutagenic
rimer. In a second PCR reaction, the amplified fragment
tself was used as a primer in a combination with another
rimer. The PCR amplification conditions consisted of an
nitial denaturation of 5 min at 95°C followed by 40
hermal cycles of 95°C for 1 min, 40°C for 1 min, and
5°C for 1 min. To generate the pETIFM1 vector, which
eleted the ATG1 codon of the ETIF gene, the first PCR
as performed with primers TX-11 (59-GCCCTCAATA-
AATTTGCCTCTTACATAT-39) and TX-5 (59-GAGGTCGA-
CAGCAGGC-39). The second PCR was performed with
primers TX-1 (59-GGGAAGCTTGAACCCGCCAAAG-39)
nd the 450-bp first PCR fragment. To generate the pE-
IFM2 vector, which deleted the ATG2 codon of the ETIF
ene, the first PCR was performed with primers TX-10
59-GCTTCAATAGTTCTGTTTGCTGCCG-39) and TX-5 (59-
GAGGTCGACAGCAGGGC-39). The second PCR was per-
formed with primer TX-1 (59-GGGAAGCTTGAACCCGC-
CAAAG-39) and the 350-bp first PCR fragment. The mu-
tant vectors pETIF1 and pETIF2 were identified by DNA
sequencing using Promega’s fmol Sequencing System
(Madison, WI).
DNA transfection and chloramphenicol
acetyltransferase (CAT) assays
L-M cells seeded at 3 3 106 cells per tissue culture
dish (60 mm) in Eagle’s minimum essential medium with
5% FBS were transfected by the liposome-mediated DNA
transfection method at 24 h (Holden et al., 1995). The
reporter plasmid was transfected in 0.45-pmol amounts.
All effector plasmids were transfected in 0.3-pmol
amounts. The total amount of DNA per transfection was
adjusted to 8 mg by the addition of pUC19. After a further
h, the cells were washed and refed with fresh medium.
t 60 h later, total cell extracts were prepared, and CAT
ctivities were assayed as described (Smith et al., 1992).
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